MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) announced the successful completion of the calibration confirmation phase of the 4Kscore™ test clinical validation study currently underway at 21 urology clinics in the United States.
Help employers find you! Check out all the jobs and post your resume.